Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight

← catalyst calendar

NCT06230523 · results posted

Sponsored by Eli Lilly and Company (industry) · LLY — their whole pipeline →.

Phase
Phase 2
Status
Completed
Study type
Interventional
Design
Randomized · Double · Treatment
Enrollment
263actual
Sites
43
Country
United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2024-02-05actualWhen the study began enrolling
Primary completion2025-05-30actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-08-14actualThe whole study's end, after follow-up
First posted2024-01-30actualWhen this record first appeared on the registry
Results posted2026-06-24actualWhen the sponsor posted results to the registry
Record updated2026-06-24actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • Obesity
  • Overweight

Interventions

  • Drug: Eloralintide — also filed as LY3841136
  • Drug: Placebo

Primary outcome

what the primary-completion date above is the date OF
Percent Change From Baseline in Body Weight at Week 48
measured Baseline, Week 48

Posted documents

hosted by the registry — we link, never re-serve
Study Protocolposted 2024-08-19 · 1.1 MB · Prot_000.pdf
Statistical Analysis Planposted 2024-11-26 · 634 KB · SAP_001.pdf

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · LLY's whole pipeline · Catalyst calendar · Every registered study · What changed